Inflammatory bowel disease (IBD) affects body image, relationships, family planning, fertility and pregnancy outcomes. However, the common misconception that IBD is a contraindication, or serious concern, in pregnancy is essentially a myth. Most patients with IBD can expect to have uneventful pregnancies. We present an overview of the management of IBD during pregnancy, including management in those planning pregnancy, the suitability of relevant medication during pregnancy and breast feeding, investigation and monitoring of IBD during pregnancy, surgical management and considerations relating to delivery. While there are some definite alterations required in the management of IBD during pregnancy, management is essentially unchanged. With close attention to aspects such as nutrition and smoking cessation, and optimal disease control in the run-up to and during pregnancy, we have an opportunity to help our patients with IBD achieve good pregnancy outcomes.
MayberryJF, WetermanIT. European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group. Gut1986;27:821–5
2.
MountifieldR, BamptonP, ProsserR, Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis2009;15:720–5
3.
CornishJ, TanE, TeareJ, A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut2007;56:830–7
4.
MahadevanU. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut2006;55:1198–206
5.
HeetunZS, ByrnesC, NearyP, Review article: Reproduction in the patient with inflammatory bowel disease. Aliment Pharmacol Ther2007;26:513–33
6.
NorgardB, HundborgHH, JacobsenBA, Disease activity in pregnant women with Crohn's disease and birth outcomes: a regional Danish cohort study. Am J Gastroenterol2007;102:1947–54
7.
MahadevanU, SandbornWJ, LiDK, Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology2007;133:1106–12
8.
NguyenGC, BoudreauH, HarrisML, Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol2009;7:329–34
9.
MoserMA, OkunNB, MayesDC, Crohn's disease, pregnancy, and birth weight. Am J Gastroenterol2000;95:1021–6
10.
AgretF, CosnesJ, HassaniZ, Impact of pregnancy on the clinical activity of Crohn's disease. Aliment Pharmacol Ther2005;21:509–13
11.
LashnerBA, ShaheenNJ, HanauerSB, Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children. Am J Gastroenterol1993;88:356–9
12.
HudsonM, FlettG, SinclairTS, Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet1997;58:229–37
13.
KaneS, KisielJ, ShihL, HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease. Am J Gastroenterol2004;99:1523–6
14.
NielsenOH, AndreassonB, BondesenS, Pregnancy in Crohn's disease. Scand J Gastroenterol1984;19:724–32
15.
NielsenOH, AndreassonB, BondesenS, Pregnancy in ulcerative colitis. Scand J Gastroenterol1983;18:735–42
16.
NwokoloCU, TanWC, AndrewsHA, Surgical resections in parous patients with distal ileal and colonic Crohn's disease. Gut1994;35:220–3
17.
RiisL, VindI, PolitiP, Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol2006;101:1539–45
18.
NorgardB, FonagerK, PedersenL, Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study. Gut2003;52:243–7
19.
Park-WyllieL, MazzottaP, PastuszakA, Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology2000;62:385–92
20.
CzeizelAE, RockenbauerM. Population-based case-control study of teratogenic potential of corticosteroids. Teratology1997;56:335–40
21.
BeaulieuDB, AnanthakrishnanAN, IssaM, Budesonide induction and maintenance therapy for Crohn's disease during pregnancy. Inflamm Bowel Dis2009;15:25–8
22.
FrancellaA, DyanA, BodianC, The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology2003;124:9–17
23.
ConnellW, MillerA. Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy. Drug Saf1999;21:311–23
24.
CarterJD, LadhaniA, RiccaLR, A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol2009;36:635–41
25.
LichtensteinGR, CohenRD, FeaganB, Safety of infliximab in Crohn's disease: data from the 5000-patient TREAT registry. Gastroenterology2004;126(Suppl.1):A54
26.
KatzJA, AntoniC, KeenanGF, Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol2004;99:2385–92
27.
VasiliauskasEA, ChurchJA, SilvermanN, Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn. Clin Gastroenterol Hepatol2006;4:1255–8
28.
HillJ, ClarkA, ScottNA. Surgical treatment of acute manifestations of Crohn's disease during pregnancy. J R Soc Med1997;90:64–6
29.
IlnyckyjA, BlanchardJF, RawsthorneP, Perianal Crohn's disease and pregnancy: role of the mode of delivery. Am J Gastroenterol1999;94:3274–8
30.
CornishJA, TanE, TeareJ, The effect of restorative proctocolectomy on sexual function, urinary function, fertility, pregnancy and delivery: a systematic review. Dis Colon Rectum2007;50:1128–38
31.
KaneS, LemieuxN. The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol2005;100:102–5
